Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SHARI A BRAZINSKY

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1245339340
CMS profile
101189
Location
SAN DIEGO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$35,892.86

113 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 3 of 3; records 101–113 of 113 matching records. This page contains 13 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SHARI A BRAZINSKY

NPI 1245339340 · CMS profile ID 101189

Allopathic & Osteopathic Physicians / Internal Medicine / Pulmonary Disease

SAN DIEGO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–113 of 113 matching records. This page contains 13 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1245339340?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SHARI A BRAZINSKY, NPI 1245339340, CMS profile ID 101189. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–113 of 113 matching records. This page contains 13 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1245339340?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). SHARI A BRAZINSKY, NPI 1245339340, CMS profile ID 101189. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–113 of 113 matching records. This page contains 13 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1245339340?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
SHARI A BRAZINSKY, NPI 1245339340, CMS profile ID 101189, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–113 of 113 matching records. This page contains 13 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1245339340?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

113 matching records · $35,892.86 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 113 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–113 of 113.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Actelion Pharmaceuticals US, Inc. $3.8602/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885376007 CMS
GENZYME CORPORATION $16.7902/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938811225 CMS
AstraZeneca Pharmaceuticals LP $14.5602/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915606417 CMS
AstraZeneca Pharmaceuticals LP $16.5302/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915079615 CMS
AstraZeneca Pharmaceuticals LP $16.0802/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915788943 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $5.3101/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887771159 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $4.6301/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887771161 CMS
Actelion Pharmaceuticals US, Inc. $3.1601/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885376005 CMS
AstraZeneca Pharmaceuticals LP $90.5301/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914710747 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12.7901/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887771163 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.2201/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955599013 CMS
AstraZeneca Pharmaceuticals LP $16.3101/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914716663 CMS
SANOFI PASTEUR INC. $15.3801/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937307957 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $9,558.15 113
PY2020 $16,241.43 80
PY2021 $12,468.16 92
PY2022 $35,892.86 113
PY2023 $8,053.19 20

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $39,371.18 13
PY2023 Principal investigator $50,790.88 50
PY2022 Principal investigator $87,924.84 50
PY2021 Principal investigator $55,878.00 29
PY2020 Principal investigator $20,741.49 4
PY2019 Principal investigator $185,079.52 15

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $46.43 12/31/2024 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK
A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma No dispute reported 06/30/2026 1155803890
Principal investigator 1 Chiesi USA, Inc. $12,583.00 11/01/2024 Non-covered Recipient Entity
INSTITUTE OF HEALTHCARE ASSESSMENT INC
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (TRITON) No dispute reported 06/30/2026 1148224510
Principal investigator 1 Chiesi USA, Inc. $1,188.00 11/01/2024 Non-covered Recipient Entity
INSTITUTE OF HEALTHCARE ASSESSMENT INC
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (TRITON) No dispute reported 06/30/2026 1148224512
Principal investigator 1 Chiesi USA, Inc. $3,817.00 11/01/2024 Non-covered Recipient Entity
INSTITUTE OF HEALTHCARE ASSESSMENT INC
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (TRITON) No dispute reported 06/30/2026 1148224514
Principal investigator 1 Chiesi USA, Inc. $242.90 10/09/2024 Non-covered Recipient Entity
INSTITUTE OF HEALTHCARE ASSESSMENT INC
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (TRITON) No dispute reported 06/30/2026 1148223890
Principal investigator 1 Chiesi USA, Inc. $475.93 10/09/2024 Non-covered Recipient Entity
INSTITUTE OF HEALTHCARE ASSESSMENT INC
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (TRITON) No dispute reported 06/30/2026 1148223892
Principal investigator 1 Chiesi USA, Inc. $3,817.00 10/04/2024 Non-covered Recipient Entity
INSTITUTE OF HEALTHCARE ASSESSMENT INC
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (TRITON) No dispute reported 06/30/2026 1148223714
Principal investigator 1 Chiesi USA, Inc. $2,500.00 09/18/2024 Non-covered Recipient Entity
INSTITUTE OF HEALTHCARE ASSESSMENT INC
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (TRITON) No dispute reported 06/30/2026 1148223060
Principal investigator 1 Chiesi USA, Inc. $2,835.00 09/06/2024 Non-covered Recipient Entity
INSTITUTE OF HEALTHCARE ASSESSMENT INC
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (TRITON) No dispute reported 06/30/2026 1148222672
Principal investigator 1 Chiesi USA, Inc. $4,178.00 07/03/2024 Non-covered Recipient Entity
INSTITUTE OF HEALTHCARE ASSESSMENT INC
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (TRITON) No dispute reported 06/30/2026 1148221128
Principal investigator 1 GlaxoSmithKline, LLC. $971.25 07/01/2024 Non-covered Recipient Entity
INSTITUTE OF HEALTHCARE ASSESSMENT INC
A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONT No dispute reported 06/30/2026 1127537358
Principal investigator 1 Mylan Specialty L.P. $5,150.00 02/06/2024 Non-covered Recipient Entity
Institute of HealthCare Assessment, Inc
A Phase 4, Randomized, Double-Blind, Double-Dummy, Parallel?Group Study Comparing Improvements in Lung Function in Adults With Severe to Very Severe Chronic Obstructive Pulmonary Disease and Suboptimal Inspiratory Flow Rate Following Once-Daily Treatment Over 12 Weeks With Either Revefenacin Inhalation Solution Delivered via Standard Jet Nebulizer or Tiotropium Delivered via a Dry Powder Inhaler (Spiriva HandiHaler) No dispute reported 06/30/2026 1141407691
Principal investigator 1 AstraZeneca Pharmaceuticals LP $1,566.67 01/24/2024 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK
A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma No dispute reported 06/30/2026 1110843652